Učitavanje...
Evaluation of E1A Double Mutant Oncolytic Adenovectors in Anti-Glioma Gene Therapy
Malignant glioma, in particular glioblastoma multiforme (GBM), represents one of the most devastating cancers currently known and existing treatment regimens do little to change patient prognosis. Conditionally replicating adenoviral vectors (CRAds) represent attractive experimental anti-cancer agen...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2008
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2365750/ https://ncbi.nlm.nih.gov/pubmed/18649343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.00000 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|